Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

 

Psoriasis (Injectable Medication)
Requirements: Adult patients (18-55) with moderate to severe psoriasis.  Must not have used biologic medications in the last 12 months and meet all other exclusion criteria.  Biologic medications include: Amevive (alefacept), Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab), Simponi (golimumab), and Stelara (ustekinumab).
Duration: 4 visits over 6 months plus 2 follow-up phone calls at 9 months and 1 year.
Incentive: $25/visit and FDA-approved study medication Humira (adalimumab), laboratory testing, and cardiovascular function testing provided at no cost.

Sponsor: Supported by Abbvie

For more information please contact:  Erika Hanami
                                                                   919-843-5126
                                                                  

 

Adult Psoriasis Research Study (Oral & Injectable Medication)
Requirements: Adult subjects over the age of 18 with moderate to severe plaque psoriasis.
Duration: Approximately 104 weeks.  For the first 16 weeks, there will be weekly visits to the clinic.  After week 16, visits will be conducted less frequently.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost.

Sponsor: Celgene

For more information please contact:  Erika Hanami
                                                                    919-843-5126
                                                                   

 

Pediatric Psoriasis (Topical Medication)
Requirements: Pediatric patients (2-12 years) with plaque type psoriasis.
Duration:
4 visits in an approximately one month time period.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

Sponsor: Galderma

For more information please contact: Emily Olsson
                                                                   919-843-5234
                                                                  

 

Pediatric Psoriasis Research Study (Topical Medication)
Requirements: Pediatric patients (2-11 years) with mild to moderate plaque type psoriasis affecting the body and scalp.  Additional treatments other than the study medication are not permitted during the study period. 
Duration: 5 total visits, 2 week screening period, 8 week treatment period, plus a follow-up phone call one week after the last study visit.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

Sponsor: Supported by Stiefel

For more information please contact:  Emily Olsson
                                                                    919-843-5234
                                                                   

 

Adult and Adolescent Acne Study (Topical Gel Medication)
Requirements: Subjects over the age of 12 with moderate facial acne. 
Duration: Approximately 12 weeks.  There will 6-7 visits to the clinic.
Incentive: Subject compensation available.  Study medication and study-related exams will be provided at no cost. 

For more information please contact:  Emily Olsson
                                                                    919-843-5234
                                                                   

 

 

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research